At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02190 ZYLOXTB
Market Closed 11-20 16:08:29
17.070
-0.590
-3.34%
High17.450
Low16.800
Vol685.60K
Open17.450
D1 Closing17.660
Amplitude3.68%
Mkt Cap5.63B
Tradable Cap5.51B
Total Shares330.00M
T/O11.66M
T/O Rate0.21%
Tradable Shares323.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Zylox-Tonbridge Updates Senior Corporate Governance Roles as New Joint Company Secretary Appointed
Zylox-Tonbridge to Take Indirect Stake in Lifetech Scientific, Building Vascular Intervention Platform; Concurrent H-Share Placement at About 13.5% Premium to Raise Net HK$864 Million
Zylox-Tonbridge and Gl Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention Platform
Zylox-Tonbridge (ZYLOXTB) Targets 10% Economic Interest in LifeTech Through HK$1.48 Billion Deal and Launches HK$875.60 Million Premium Share Placement
Zylox-Tonbridge to Take Indirect Stake in Lifetech Scientific, Building a Vascular Intervention Platform with a Concurrent H-Share Placement at About 13.5% Premium to Raise Roughly HK$864 Million Net
Zylox-Tonbridge Medical Technology Co Ltd is a China-based company primarily engaged in the provision of solutions to patients and physicians with the product portfolio covering neurovascular interventional devices and peripheral vascular interventional devices. The neurovascular interventional devices primarily include SilverSnake Intracranial Support Catheter, Phoenix Neurovascular Embolization Coil, Tonbridge Kylin Flow Diverter, Thrombite Clot Retriever Device and Beidou SS Neurovascular Guidewire. The peripheral vascular interventional devices primarily include UltraFree Drug Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, ZYLOX Octoplus Retrievable Inferior Vena Cava Filter, Snare Retrieval Kit for Inferior Vena Cava Filter and ZYLOX Swan Endovenous Radiofrequency Ablation Catheter. The Company primarily operates its businesses in the domestic market and overseas markets, including Germany, France, Italy, and Turkiye.